Diality, Inc.

Diality, Inc. is a US-based company focused on enhancing renal care through innovative hemodialysis solutions. Their flagship product, the Moda-flx Hemodialysis System™, is designed to improve treatment delivery and patient outcomes. Diality, Inc.

specializes in developing advanced hemodialysis systems. Founded in 2015 in Irvine, US, the company has successfully completed 6 deals, with the most recent deal occurring on August 9, 2023. The company raised USD 28. 00 mn in its latest funding round.

Osman Khawar leads the company as CEO. Diality is focused on advancing renal care through its flagship product, the Moda-flx Hemodialysis System™, which is designed to enhance the delivery of hemodialysis treatment. This system empowers healthcare professionals by offering a flexible platform that accommodates a wide range of dialysis prescriptions, thereby optimizing clinical workflows. The Moda-flx system aims to improve patient care through its user-friendly design, which shortens training time for clinicians, including those outside of nephrology.

Additionally, the system's mobility is enhanced by its custom cart, allowing for ease of movement within healthcare facilities. Diality targets healthcare providers across North America, working with clinics and hospitals to deliver effective and personalized dialysis treatment solutions. Diality's revenue model is primarily based on the sale and distribution of the Moda-flx Hemodialysis System™ to healthcare facilities. The company engages in direct B2B transactions with hospitals and dialysis centers, which involves a structured pricing strategy tailored to the operational needs of these healthcare entities.

These transactions may include service agreements and maintenance contracts that ensure the longevity and reliability of the hemodialysis systems. While specific pricing structures for the Moda-flx system are not disclosed, the offerings are designed to align with the financial capabilities and requirements of healthcare providers, facilitating increased access to advanced renal care technologies. Through strategic partnerships and membership in coalitions such as Kidney Care Partners, Diality connects with a broad network of stakeholders, enhancing its market reach. In August 2023, Diality, Inc.

raised USD 28. 00 mn in venture funding to support its pre-commercialization activities and its 510(k) filing. The company plans to expand the reach of the Moda-flx Hemodialysis System™ and is actively designing new products aimed at further enhancing renal care. Diality is also looking to enter new geographic markets, focusing on expanding its presence in North America and potentially internationally within the next few years.